Cresco Labs Inc. Gains Losses On Fair Value Adjustment Biological Assets
Cresco Labs Inc. (CRLBF) reported Gains Losses On Fair Value Adjustment Biological Assets of $293.12 million for the 12-month period ending 2020-12-31, per its 40-F/A filed 2021-04-29.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets · last filed 2021-04-29
| Period end | Gains Losses On Fair Value Adjustment Biological Assets 12 month |
|---|---|
| 2020-12-31 | $293.12M 40-F/A · filed 2021-04-29 |
| 2019-12-31 | $109.53M 40-F/A · filed 2021-04-29 |